Request Deal Involvement

OrbiMed, Novo Holdings and Blue Owl Capital led a $200m Series A round in Windward Bio.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Homburger

legal advisors

Homburger

Ropes & Gray

legal advisors

Ropes & Gray

or

Principals

 WINDWARD BIO

target

WINDWARD BIO

OMEGA FUNDS

bidder

OMEGA FUNDS

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

QUAN CAPITAL

bidder

QUAN CAPITAL

PIVOTAL BIOVENTURE PARTNERS LLC

bidder

PIVOTAL BIOVENTURE PARTNERS LLC

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

BLUE OWL CAPITAL

bidder

BLUE OWL CAPITAL

QIMING VENTURE PARTNERS

bidder

QIMING VENTURE PARTNERS

SR ONE LTD

bidder

SR ONE LTD

RTW INVESTMENTS

bidder

RTW INVESTMENTS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite